2 completed, 1 not yet recruiting, 1 withdrawn. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Methylphenidate Pill: new trials by email Literature Review of Methylphenidate Pill trials Research Report on Methylphenidate Pill
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylphenidate and Response to Alcohol Cues Methylphenidate Pill, Placebo Pill - Alcohol Use Disorder | Phase 2 | Not yet recruiting | University of Florida | 50 | 2026-10-01 | 2026-08-20 |
| Methylphenidate and Response to Alcohol Cues Pilot Study Methylphenidate Pill - Alcohol Use Disorder, Attention Deficit Hyperactivity Disorder | Early Phase 1 | Completed | University of Florida | 31 | 2024-03-20 | 2026-02-10 |
| Methylphenidate for Cocaine Dependence Methylphenidate Pill - Substance-Related Disorders | Phase 2 | Withdrawn | ANRS, Emerging Infectious Diseases | 2018-06-01 | 2018-07-20 | |
| Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI Methylphenidate Pill, Oral Placebo, Intravenous Placebo - Normal Physiology | Phase 1 | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 25 | 2018-01-29 | 2024-05-28 |
Alcoholism (2) · Attention Deficit Disorder with Hyperactivity (2) · Substance-Related Disorders (1)
University of Florida (2) · ANRS, Emerging Infectious Diseases (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)
United States (3) · France (1)
Amine Benyamina, Pr (1) · Dardo G Tomasi, Ph.D. (1)
PMID 36765261, PMID 37938560, PMID 38109535, PMID 38326458
R01AA032400 (1)